2019 annual financial data
Solid Biosciences 2019 Operating cash flow growth
Direct answer
Operating cash flow growth was -32.08%.
Operating income was -119,318,000 USD and net income was -117,223,000 USD.
Operating cash flow was -92,714,000 USD.
Get free Solid Biosciences email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -119,318,000 USD
- Net income
- -117,223,000 USD
- Operating cash flow
- -92,714,000 USD